virus
infect
oblig
parasit
replic
live
cell
anim
plant
fungi
bacteria
although
extrem
small
size
simpl
structur
virus
caus
numer
diseas
cancer
autoimmun
diseas
immunodefici
well
organspecif
infecti
diseas
includ
common
cold
influenza
diarrhea
hepat
etc
recent
progress
formul
antivir
therapi
vaccin
help
prevent
shorten
durat
decreas
sever
viral
infect
antivir
agent
design
target
viral
compon
mutat
viral
genom
often
result
drug
resist
immun
evas
creat
major
hurdl
antivir
therapi
vaccin
develop
addit
continu
emerg
new
infecti
agent
ebola
viru
middl
east
respiratori
syndrom
coronaviru
merscov
necessit
advanc
novel
therapeut
approach
accordingli
great
attent
recent
drawn
develop
antivir
broadspectrum
efficaci
immunomodul
improv
host
resili
increas
host
resist
viral
infect
korean
ginseng
root
panax
ginseng
meyer
one
popular
medicin
plant
use
tradit
medicin
east
asian
countri
includ
korea
ginseng
contain
variou
pharmacolog
activ
substanc
ginsenosid
polysaccharid
polyacetylen
phytosterol
essenti
oil
among
ginsenosid
consid
major
bioactiv
compound
korean
red
ginseng
krg
heatprocess
ginseng
prepar
repeat
process
steam
airdri
fresh
ginseng
krg
shown
possess
enhanc
pharmacolog
activ
stabil
compar
fresh
ginseng
chang
chemic
constitu
ginsenosid
occur
steam
process
current
numer
studi
report
benefici
effect
krg
divers
diseas
cancer
immun
system
disord
neuron
diseas
cardiovascular
diseas
addit
krg
purifi
compon
also
shown
possess
protect
activ
microbi
infect
review
summar
current
knowledg
effect
krg
compon
infect
human
pathogen
virus
discuss
therapeut
potenti
krg
antivir
vaccin
adjuv
respiratori
syncyti
viru
rsv
lead
caus
lower
respiratori
tract
infect
viral
infect
show
mild
indistinguish
symptom
common
cold
adult
healthi
children
also
caus
sever
lower
respiratori
tract
diseas
pneumonia
bronchiol
prematur
babi
infant
underli
health
condit
immunocompromis
patient
effect
antivir
therapi
prevent
vaccin
earli
life
current
avail
matern
vaccin
consid
possibl
strategi
provid
rsv
antibodi
protect
young
infant
kang
laboratori
georgia
state
univers
ga
publish
sever
studi
immunomodulatori
antivir
effect
krg
extract
rge
rsv
although
formalininactiv
rsv
firsv
vaccin
develop
immun
firsv
halt
vaccin
children
experienc
sever
respiratori
diseas
natur
rsv
infect
sever
form
diseas
caus
firsv
attribut
strong
thelper
type
immun
respons
rge
shown
mitig
respons
enhanc
thelper
type
respons
immun
mice
immun
respons
intrins
thu
rgetreat
mice
immun
firsv
show
improv
clinic
outcom
via
increas
immunoglobulin
antibodi
level
interferon
ifn
product
accompani
decreas
product
weight
loss
rsv
infect
data
indic
rge
possess
immunomodulatori
effect
balanc
immun
respons
protect
host
sever
pulmonari
inflamm
upon
firsv
immun
rsv
infect
addit
rge
protect
human
epitheli
cell
rsvinduc
cell
death
viral
replic
inhibit
product
proinflammatori
cytokin
vitro
upon
rsv
infect
moreov
rge
treatment
improv
clinic
outcom
prevent
weight
loss
increas
viral
clearanc
product
bronchoalveolar
lavag
cell
mice
rge
also
increas
number
dendrit
cell
cell
cell
bronchoalveolar
lavag
fluid
taken
togeth
studi
demonstr
ginseng
immunomodulatori
antivir
effect
rsv
infect
multipl
mechan
studi
requir
elucid
underli
immunoregulatori
antivir
mechan
molecular
level
rhinoviru
major
caus
common
cold
rhinoviru
transmit
persontoperson
via
contact
aerosol
caus
upper
respiratori
ill
although
gener
mild
selflimit
rhinoviru
infect
may
caus
asthma
chronic
obstruct
pulmonari
diseas
chronic
infect
lead
sever
complic
asthmat
elderli
peopl
immunocompromis
patient
current
cure
prevent
rhinoviru
infect
treatment
mainli
reli
symptom
allevi
use
nonsteroid
antiinflammatori
drug
nsaid
nasal
decongest
antihistamin
nonetheless
consist
effort
made
identifi
effect
prevent
antivir
medic
rhinoviru
attempt
investig
effect
ginsenosid
rhinoviru
infect
song
et
al
examin
antivir
activ
protopanaxatriol
pt
type
ginsenosid
rf
protopanaxadiol
pd
type
ginsenosid
rc
rd
result
show
pttype
ginsenosid
protect
hela
cell
human
rhinoviru
induc
cell
death
determin
sulforhodamin
b
stain
viabl
cell
morpholog
assess
howev
pdtype
ginsenosid
show
protect
effect
even
stimul
cell
death
significantli
impli
structuredepend
effect
ginsenosid
select
antivir
activ
panaxatrioltyp
ginsenosid
also
found
case
coxsackieviru
describ
futur
studi
need
elucid
relationship
antivir
activ
structur
differ
among
panaxadiol
panaxatrioltyp
ginsenosid
influenza
viru
common
human
respiratori
pathogen
caus
annual
endem
period
pandem
infect
three
type
influenza
virus
b
c
human
influenza
b
virus
caus
season
diseas
nearli
everi
winter
wherea
influenza
c
viru
caus
mild
respiratori
diseas
influenza
virus
virul
human
pathogen
serotyp
classifi
term
base
viral
surfac
protein
hemagglutinin
h
neuraminidas
n
novel
mutant
strain
continu
emerg
caus
influenza
pandem
outbreak
histor
renown
lethal
strain
spanish
influenza
asian
influenza
russian
influenza
hong
kong
influenza
swineorigin
influenza
recent
found
mexico
ampl
studi
conduct
demonstr
antivir
activ
rge
purifi
compound
present
ginseng
influenza
viru
infect
vitro
vivo
rge
treatment
improv
viabil
human
alveolar
epitheli
cell
upon
infect
accompani
decreas
virusinduc
cytokin
secret
reactiv
oxygen
speci
ro
format
protopanaxatrioltyp
ginsenosid
shown
protect
human
umbil
vein
endotheli
cell
huvec
avian
influenzainduc
apoptosi
inhibit
virusinduc
interferoninduc
product
inhibitori
effect
rge
viral
replic
also
test
canin
kidney
mdck
cell
use
pandem
viru
vivo
studi
rge
ginseng
polysaccharid
gp
ginseng
saponin
oral
administ
mice
ferret
prior
viral
infect
protect
effect
evalu
measur
bodi
weight
surviv
rate
lung
viral
titer
cytokin
product
histopatholog
etc
antivir
effect
strain
wide
test
avian
influenza
also
examin
detail
rge
report
antivir
effect
gp
effect
saponin
effect
antivir
activ
rge
gp
ginseng
saponin
fraction
also
compar
use
strain
yin
et
al
show
gp
effect
improv
symptom
influenza
viru
infect
follow
rge
saponin
order
addit
antivir
activ
rge
also
play
role
mucos
adjuv
influenza
viru
viral
infect
administ
inactiv
viru
rge
intranas
immun
mice
produc
increas
level
influenza
virusspecif
antibodi
improv
neutral
activ
blood
mucos
secret
notabl
iga
antibodi
lung
rge
plu
viru
immun
also
result
enhanc
secret
cytokin
splenocyt
upon
challeng
infect
although
type
respons
remark
adjuv
effect
rge
compar
convent
adjuv
aluminum
hydroxid
cholera
toxin
addit
immun
mice
inactiv
influenza
antigen
ginsenosid
result
increas
immun
respons
elev
cell
activ
secret
serumspecif
hemagglutin
inhibit
titer
increas
vitro
stimul
splenocyt
produc
higher
level
cytokin
ginsenosid
readminist
mice
furthermor
dietari
intak
rge
korean
red
ginseng
saponin
krg
also
shown
improv
vaccin
efficaci
increas
antiinfluenza
viru
aspecif
igg
titer
surviv
rate
addit
gp
induc
crossprotect
vaccin
efficaci
mice
vaccin
influenza
viruslik
particl
vlp
origin
togeth
gp
immun
mice
develop
heterosubtyp
protect
surviv
lethal
challeng
viru
taken
togeth
data
suggest
use
rge
krg
ginsenosid
gp
adjuv
dietari
supplement
enhanc
vaccineinduc
immun
respons
improv
protect
influenza
viru
infect
human
immunodefici
viru
hiv
belong
genu
lentiviru
famili
retrovirida
two
type
hiv
character
major
type
hiv
account
infect
worldwid
virul
infecti
mainli
seen
west
africa
lower
infect
welldefin
stage
hiv
diseas
progress
acut
infect
clinic
latenc
acquir
immunodefici
syndrom
aid
hivposit
patient
diagnos
aid
hisher
cell
count
fall
hiv
treatment
highli
activ
antiretrovir
therapi
haart
involv
combin
multipl
drug
differ
mechan
action
haart
effect
suspend
prevent
diseas
progress
one
stage
next
prolong
live
hivposit
patient
dramat
lower
viral
load
maintain
immun
system
function
prevent
opportunist
infect
combin
zidovudin
monotherapi
haart
rge
shown
exert
antivir
effect
maintain
cell
count
delay
occurr
resist
mutat
patient
rge
treatment
alon
even
show
signific
antihiv
effect
impli
rge
intak
may
becom
altern
form
treatment
patient
neg
factor
nef
virul
factor
requir
achiev
high
viru
load
progress
aid
long
termin
repeat
ltr
act
promot
entir
viral
genom
stimul
viral
genom
replic
wherea
groupspecif
antigen
gag
promot
format
fulli
infecti
virion
interestingli
rge
intak
increas
frequenc
gross
delet
nef
gene
ltrgag
gene
lead
delay
diseas
progress
increas
surviv
rate
patient
although
studi
evalu
effect
ginseng
carri
patient
sever
vitro
studi
also
perform
exampl
homodimer
protein
quinqueginsin
isol
root
american
ginseng
panax
quinquefolium
xylanas
isol
root
panax
notoginseng
shown
inhibit
revers
transcriptas
cellfre
system
addit
ginsenosid
ginsenosid
compound
k
report
inhibit
cytoprotect
effect
may
contribut
longterm
surviv
persist
product
cell
constitut
express
transactiv
tat
protein
addit
antivir
effect
ginseng
interact
antihiv
drug
chang
pharmacokinet
properti
shi
et
al
report
ginsenosid
increas
accumul
decreas
efflux
ritonavir
pglycoprotein
pgp
cell
cell
vivo
studi
use
rat
confirm
intraven
administr
ginsenosid
inhibit
ritonavir
efflux
increas
plasma
level
ritonavir
howev
american
ginseng
panax
quinquefolium
affect
pharmacokinet
antihiv
drug
cotreat
human
although
induc
phase
enzym
quinon
reductas
kaempferol
isol
ginseng
also
report
inhibit
pgpmediat
efflux
ritonavir
cytochrom
activ
vitro
confirm
whether
kaempferol
would
inde
induc
level
ritonavir
vivo
herpesvirus
group
larg
dna
virus
caus
lytic
persist
latentrecurr
infect
human
herpesvirus
hhv
divid
three
subfamili
alphaherpesvirina
includ
herp
simplex
herp
simplex
varicellazost
viru
vzv
betaherpesvirina
gammaherpesvirina
base
differ
factor
tissu
tropism
pathogenesi
site
latent
infect
typic
transmit
childhood
contact
infect
skin
associ
orofaci
infect
enceph
although
transmit
sexual
activ
caus
genit
herp
mostli
notoginsenosid
dammaranetyp
saponin
panax
notoginseng
report
show
antihsv
activ
inhibit
penetr
vero
cell
anoth
vitro
studi
shown
ginsenosid
promot
cell
prolifer
inhibit
apoptosi
human
glioma
cell
upon
hsv
infect
suggest
potenti
applic
ginsenosid
prevent
neuron
cell
death
viral
enceph
activ
rge
also
report
vivo
balbc
mice
administ
mgkg
mgkg
rge
oral
day
infect
rgetreat
mice
becam
resist
vagin
system
infect
shown
decreas
clinic
sever
increas
surviv
rate
viral
clearanc
rge
also
stimul
secret
vagin
lavag
fluid
increas
express
granzym
b
fasligand
mrna
lymph
node
vagin
tissu
suggest
rge
protect
host
infect
stimul
natur
killer
nk
cell
activ
given
divers
antivir
activ
rge
inhibit
viral
penetr
cell
death
nk
cell
activ
prophylact
use
rge
would
benefici
prevent
allevi
primari
recurr
hsv
infect
combin
convent
antivir
drug
hepat
viru
hav
positivesens
singlestrand
rna
viru
belong
famili
picornavirida
unlik
hepat
b
viru
hbv
transmit
exposur
blood
variou
bodi
fluid
infect
peopl
hav
larg
transmit
rout
caus
acut
hepat
although
hepat
infect
lead
chronic
liver
diseas
low
mortal
may
caus
enerv
symptom
fulmin
hepat
acut
liver
failur
current
specif
antivir
agent
avail
hav
thu
prevent
via
vaccin
improv
hygien
sanit
effect
approach
hav
infect
lee
et
al
examin
antivir
effect
rge
purifi
ginsenosid
hav
infect
demonstr
pretreat
cotreat
rge
ginsenosid
cell
deriv
monkey
kidney
decreas
hav
titer
upon
hav
infect
vitro
although
antivir
effect
rge
ginsenosid
remain
limit
vitro
model
report
suggest
regular
intak
krg
dietari
supplement
may
help
prevent
hav
infect
hepat
b
viru
hbv
doublestrand
dna
viru
classifi
famili
hepadnavirida
hbv
caus
acut
hepat
also
develop
longterm
chronic
infect
chronic
hepat
b
lead
lifethreaten
cirrhosi
hepatocarcinoma
hbv
infect
one
seriou
health
problem
worldwid
viral
replic
larg
amount
hbv
surfac
antigen
hbsag
hbv
envelop
antigen
hbeag
virion
releas
blood
accordingli
diagnost
test
hbv
infect
involv
detect
viral
antigen
virion
antibodi
viral
antigen
antihbv
effect
ginsenosid
welldescrib
ginsenosid
remark
inhibit
secret
hbsag
hbeag
viral
particl
hbvinfect
cell
anoth
mechanist
studi
reveal
ginsenosid
downregul
tnf
receptorassoci
factor
transform
growth
factor
activ
inhibit
mitogenactiv
protein
kinas
mapk
signal
pathway
imped
cjun
phosphoryl
reduc
express
consequ
express
proinflammatori
cytokin
reduc
although
antiinflammatori
activ
ginsenosid
explicitli
describ
unclear
antiinflammatori
effect
ginsenosid
affect
hbv
replic
futur
studi
strive
better
understand
link
antihbv
antiinflammatori
activ
ginsenosid
noroviru
positivesens
singlestrand
rna
viru
caus
nausea
vomit
abdomin
pain
diarrhea
human
viru
spread
rout
ingest
contamin
water
food
especi
fish
shellfish
human
noroviru
cultur
noroviru
surrog
felin
caliciviru
fcv
murin
noroviru
mnv
tulan
viru
tv
use
test
antivir
activ
natur
chemic
compound
noroviru
fcv
mnv
similar
genom
organ
physic
properti
replic
cycl
human
noroviru
cultiv
felin
kidney
crfk
cell
murin
cell
respect
lee
et
al
shown
pretreat
crfk
cell
rge
ginsenosid
significantli
reduc
fcv
mnv
titer
vitro
wherea
cotreat
posttreat
antivir
effect
subsequ
studi
research
group
demonstr
rge
ginsenosid
pretreat
induc
antivir
protein
fcvinfect
crfk
cell
express
zinc
finger
antivir
protein
shorter
isoform
zap
mx
protein
ifninduc
protein
antivir
activ
increas
contribut
decreas
viral
titer
crfk
cell
futur
studi
need
establish
cultur
system
human
noroviru
subsequ
evalu
antivir
effect
rge
ginsenosid
human
noroviru
rotaviru
lead
caus
acut
gastroenter
young
children
age
year
two
live
oral
rotaviru
vaccin
rotarix
glaxosmithklin
uniti
kingdom
rotateq
merck
unit
state
avail
implement
rotaviru
vaccin
childhood
immun
program
significantli
reduc
morbid
mortal
associ
rotaviru
infect
nevertheless
antivir
drug
treat
rotaviru
infect
mostli
therapeut
involv
prevent
dehydr
tradit
medicin
ginseng
known
improv
gastrointestin
function
prevent
gastrointestin
problem
diarrhea
recent
studi
research
activ
constitu
ginseng
report
two
pectic
polysaccharid
isol
hot
water
extract
ginseng
prevent
cell
death
viral
infect
polysaccharid
name
virucid
effect
inhibit
viral
attach
host
cell
therebi
protect
virusinduc
cell
death
given
result
addit
report
pectintyp
polysaccharid
ginseng
inhibit
adher
helicobact
pylori
gastric
epitheli
cell
abil
porphyromona
gingivali
agglutin
erythrocyt
evalu
antimicrobi
effect
acid
polysaccharid
structur
pectin
merit
human
enteroviru
coxsackieviru
two
major
caus
handfootandmouth
diseas
hfmd
young
children
although
hfmd
mild
selflimit
diseas
character
fever
rash
bump
blister
ulcer
mouth
feet
hand
buttock
affect
children
may
develop
neurolog
cardiovascular
respiratori
complic
rare
case
present
specif
treatment
vaccin
hfmd
order
identifi
ginsenosid
antivir
activ
song
et
al
test
panaxadioltyp
ginsenosid
rc
rd
panaxatrioltyp
ginsenosid
rf
found
ginsenosid
antivir
activ
infect
vero
cell
determin
whether
anticytopath
effect
due
virucid
activ
inhibit
viral
attach
coxsackieviru
positivesens
singlestrand
rna
viru
belong
picornavirida
coxsackievirus
divid
group
viru
serotyp
group
b
viru
six
serotyp
among
common
pathogen
coxsackieviru
caus
hfmd
describ
coxsackieviru
caus
myocard
asept
mening
pancreat
present
effect
therapeut
agent
ribavirin
avail
infect
despit
weak
antivir
activ
protopanaxtriol
one
major
triterpen
isol
panax
notoginseng
shown
protopanaxtriol
potent
activ
vitro
vivo
protopanaxtriol
inhibit
replic
hela
cell
even
lower
ribavirin
indic
stronger
antivir
effect
ribavirin
vivo
experi
show
treatment
mice
protopanaxtriol
significantli
improv
myocard
repres
decreas
activ
lactas
dehydrogenas
creatin
kinas
marker
myocardi
injuri
addit
panaxatrioltyp
ginsenosid
ginsenosid
rf
also
show
signific
activ
repres
decreas
cytopath
effect
increas
cell
viabil
infect
vero
cell
activ
ginsenosid
rf
compar
ribavirin
howev
panaxadioltyp
ginsenosid
rc
rd
exhibit
activ
swift
emerg
new
infecti
virus
drugresist
variant
limit
avail
effect
antivir
agent
vaccin
thu
develop
broadspectrum
antivir
immunomodul
agent
stimul
host
immun
improv
host
resili
essenti
although
ginseng
exert
direct
antivir
effect
inhibit
viral
attach
membran
penetr
replic
foremost
antivir
activ
ginseng
attribut
enhanc
host
immun
futur
studi
includ
identif
essenti
compon
respons
enhanc
immun
viral
attack
none
declar
